pharma · Rectal Cancer · Fanconi Anemia · RCKT
Rocket Pharmaceuticals
Rocket Pharmaceuticals B.V.
Rocket Pharmaceuticals is a pharma organization headquartered in Cranbury, USA. It trades on NYSE under ticker RCKT. Primary therapeutic focus areas include Rectal Cancer, Fanconi Anemia, Danon Disease, PKP2 Arrhythmogen
9 Cedarbrook Dr, Cranbury, New Jersey 08512, US HQ
2015 Founded
226 Employees
Public company Type
RCKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 9 Cedarbrook Dr, Cranbury, New Jersey 08512, US
- Founded
- 2015
- Employees
- 226
- Programs
- 11
- Drugs
- 10
- Patents
- 1
RP-A601
Phase 1 · gene therapy · PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) is a Phase 1 program (gene_therapy) at Rocket Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Internal code RP-A601-0323
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Rocket Pharmaceuticals B.V.
- Phase
- Phase 1
- Modality
- gene_therapy
- Indication
- PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
- Status
- active
- Trials
- 1